Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses.
Journal
NPJ vaccines
ISSN: 2059-0105
Titre abrégé: NPJ Vaccines
Pays: England
ID NLM: 101699863
Informations de publication
Date de publication:
20 Jun 2024
20 Jun 2024
Historique:
received:
08
02
2024
accepted:
11
06
2024
medline:
21
6
2024
pubmed:
21
6
2024
entrez:
20
6
2024
Statut:
epublish
Résumé
The ChAdOx1 nCoV-19 (COVISHIELD) vaccine has emerged as a pivotal tool in the global fight against the COVID-19 pandemic. In our previous study eligible subjects were supplemented with calcifediol, a direct precursor to the biologically active form of vitamin D, calcitriol with an objective to enhance the immunogenicity of the COVISHIELD vaccine. Herein we investigated the effects of calcifediol supplementation on gene expression profiles in individuals who received the COVISHIELD vaccine. Peripheral blood mononuclear cells were isolated from vaccinated individuals with and without calcifediol supplementation at baseline, 3rd and 6th month, and the gene expression profiles were analyzed using high-throughput sequencing. The results revealed distinct patterns of gene expression associated with calcifediol supplementation, suggesting potential molecular mechanisms underlying the beneficial effects of calcifediol in improving the efficacy of COVISHIELD vaccine via augmentation of T cell activation, proliferation and T cell memory responses. Additionally, there was upregulation of NOD like receptor, JAK/STAT and TGF beta signaling pathways. Calcifediol supplementation in vaccinated individuals also downregulated the pathways related to the Coronavirus disease. Taken together, our findings provide valuable insights into the interplay between vitamin D receptor (VDR) signaling and vaccine-induced immune responses and offer another approach in improving vaccination induced antiviral responses.
Identifiants
pubmed: 38902265
doi: 10.1038/s41541-024-00909-w
pii: 10.1038/s41541-024-00909-w
doi:
Types de publication
Journal Article
Langues
eng
Pagination
114Informations de copyright
© 2024. The Author(s).
Références
Bikle, D. & Christakos, S. New aspects of vitamin D metabolism and action - addressing the skin as source and target. Nat. Rev. Endocrinol. 16, 234–252, https://doi.org/10.1038/s41574-019-0312-5 (2020).
doi: 10.1038/s41574-019-0312-5
pubmed: 32029884
Umesono, K., Murakami, K. K., Thompson, C. C. & Evans, R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65, 1255–1266, https://doi.org/10.1016/0092-8674(91)90020-y (1991).
doi: 10.1016/0092-8674(91)90020-y
pubmed: 1648450
pmcid: 6159884
Holick, M. F. Vitamin D deficiency. N. Engl. J. Med. 357, 266–281, https://doi.org/10.1056/NEJMra070553 (2007).
doi: 10.1056/NEJMra070553
pubmed: 17634462
Adams, J. S. & Hewison, M. Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab. 4, 80–90, https://doi.org/10.1038/ncpendmet0716 (2008).
doi: 10.1038/ncpendmet0716
pubmed: 18212810
pmcid: 2678245
Baeke, F. et al. Vitamin D: Modulator of the immune system. Curr. Opin. Pharmacol. 10, 482–496, https://doi.org/10.1016/j.coph.2010.04.001 (2010).
doi: 10.1016/j.coph.2010.04.001
pubmed: 20427238
Liu, P. T. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770–1773, https://doi.org/10.1126/science.1123933 (2006).
doi: 10.1126/science.1123933
pubmed: 16497887
Jeffery, L. E. et al. Vitamin D in rheumatoid Arthritis—towards clinical application. Nat. Rev. Rheumatol. 12, 201–210, https://doi.org/10.1038/nrrheum.2015.140 (2015).
doi: 10.1038/nrrheum.2015.140
pubmed: 26481434
Cutolo, M. et al. Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19. Nat. Rev. Rheumatol. 19, 265–287, https://doi.org/10.1038/s41584-023-00944-2 (2023).
doi: 10.1038/s41584-023-00944-2
pubmed: 36977791
pmcid: 10043872
Zhu, Z. et al. Association between Vitamin D and influenza: meta-analysis and systematic review of randomized controlled trials. Front. Nutr. 8, 799709, https://doi.org/10.3389/fnut.2021.799709 (2022).
doi: 10.3389/fnut.2021.799709
pubmed: 35071300
pmcid: 8777486
Jain, A. et al. Analysis of Vitamin D Level among asymptomatic and critically Ill COVID-19 patients and its correlation with inflammatory markers. Sci. Rep. 10, 20191, https://doi.org/10.1038/s41598-020-77093-z (2020).
doi: 10.1038/s41598-020-77093-z
pubmed: 33214648
pmcid: 7677378
Nielsen, N. M. et al. Vitamin D status and severity of COVID-19. Sci. Rep. 12, 19823, https://www.nature.com/articles/s41598-022-21513-9 (2022).
Petrelli, F. et al. Vitamin D3 and COVID-19 outcomes: an umbrella review of systematic reviews and meta-analyses. Antioxidants 12, 247, https://doi.org/10.3390/antiox12020247 (2023).
doi: 10.3390/antiox12020247
pubmed: 36829806
pmcid: 9952713
Kaya, M. O. et al. The role of Vitamin D Deficiency on the Covid-19: a systematic review and meta-analysis of observational studies. Epidemiol. Health 43, e2021074, https://doi.org/10.4178/epih.e2021074 (2021).
doi: 10.4178/epih.e2021074
pubmed: 34607398
pmcid: 8769802
Dancer, R. C. A. et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax 70, 617–624, https://doi.org/10.1136/thoraxjnl-2014-206680 (2015).
doi: 10.1136/thoraxjnl-2014-206680
pubmed: 25903964
Holick, M. F. Vitamin D status: measurement, interpretation, and clinical application. Ann. Epidemiol. 19, 73–78, https://doi.org/10.1016/j.annepidem.2007.12.001 (2009).
doi: 10.1016/j.annepidem.2007.12.001
pubmed: 18329892
Jodar, E. et al. Calcifediol: A review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency. Eur. J. Nutr. 62, 1579–1597, https://doi.org/10.1007/s00394-023-03103-1 (2023).
doi: 10.1007/s00394-023-03103-1
pubmed: 36862209
pmcid: 9979899
Pérez‐Castrillón, J. L. et al. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial. J. Bone Miner. Res. 36, 1967–1978, https://doi.org/10.1002/jbmr.4387 (2021).
doi: 10.1002/jbmr.4387
pubmed: 34101900
Bhat, S. et al. Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 NCoV-19 vaccine: a prospective open-label, placebo-controlled, clinical trial. J. Infect. 86, e120–e122, https://doi.org/10.1016/j.jinf.2023.03.004 (2023).
doi: 10.1016/j.jinf.2023.03.004
pubmed: 36889512
pmcid: 10008192
Love, M. et al. Moderated estimation of fold change and dispersion for RNA-Seq Data with DESeq2. Genome Biol. 15, 550, https://doi.org/10.1186/s13059-014-0550-8 (2014).
doi: 10.1186/s13059-014-0550-8
pubmed: 25516281
pmcid: 4302049
Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106, https://doi.org/10.1186/gb-2010-11-10-r106 (2010).
doi: 10.1186/gb-2010-11-10-r106
pubmed: 20979621
pmcid: 3218662
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc.: Series B (Methodological) 57, 289–300 (1995).
Koivisto, O. et al. Key Vitamin D target genes with functions in the immune system. Nutrients 12, 1140, https://doi.org/10.3390/nu12041140 (2020).
doi: 10.3390/nu12041140
pubmed: 32325790
pmcid: 7230898
Kongsbak, M. et al. The Vitamin D receptor and T cell function. Front. Immunol. 4, 148, https://doi.org/10.3389/fimmu.2013.00148 (2013).
doi: 10.3389/fimmu.2013.00148
pubmed: 23785369
pmcid: 3684798
Wei, R. & Christakos, S. Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D. Nutrients 7, 8251–8260, https://doi.org/10.3390/nu7105392 (2015)
doi: 10.3390/nu7105392
pubmed: 26404359
pmcid: 4632412
Hewison, M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol. Metab. Clin. North Am. 39, 365–379, https://doi.org/10.1016/j.ecl.2010.02.010 (2010).
doi: 10.1016/j.ecl.2010.02.010
pubmed: 20511058
pmcid: 2879394
Basyreva, L. Y. et al. Effect of vitamin D3 in combination with omega-3 polyunsaturated fatty acids on NETosis in type 2 diabetes mellitus patients. Oxid. Med. Cell. Longev. 2021, 1–10, https://doi.org/10.1155/2021/8089696 (2021).
doi: 10.1155/2021/8089696
Martens, P.-J. et al. Vitamin D’s effect on immune function. Nutrients 12, 1248, https://doi.org/10.3390/nu12051248 (2020).
doi: 10.3390/nu12051248
pubmed: 32353972
pmcid: 7281985
Handono, K. et al. Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus. Acta Med. Indonesiana 46, 189–198 (2014).
Seif, F. et al. The Role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun. Signal. 15, 23, https://doi.org/10.1186/s12964-017-0177-y (2017).
doi: 10.1186/s12964-017-0177-y
pubmed: 28637459
pmcid: 5480189
Van Coillie, S. et al. Molecular and cellular functions of CTLA-4. Adv. Exp. Med. Biol. 1248, 7–32, https://doi.org/10.1007/978-981-15-3266-5_2 (2020).
doi: 10.1007/978-981-15-3266-5_2
pubmed: 32185705
Nakagawa, H. et al. Instability of Helios-Deficient tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity. Proc. Natl Acad. Sci. USA 113, 6248–6253, https://doi.org/10.1073/pnas.1604765113 (2016).
doi: 10.1073/pnas.1604765113
pubmed: 27185917
pmcid: 4896716
Török, K. et al. Complement receptor Type 1 (CR1/CD35) expressed on activated human CD4+ T cells contributes to generation of regulatory T Cells. Immunol. Lett. 164, 117–124, https://doi.org/10.1016/j.imlet.2015.02.009 (2015).
doi: 10.1016/j.imlet.2015.02.009
pubmed: 25742728
Shaw, L. A. et al. Id3 expression identifies CD4 + memory Th1 cells. Proc. Natl Acad. Sci. 119, e2204254119, https://doi.org/10.1073/pnas.2204254119 (2022).
doi: 10.1073/pnas.2204254119
pubmed: 35858332
pmcid: 9303986
van Leeuwen, M. M. et al. Generation and maintenance of memory CD4+ T cells. Curr. Opin. Immunol. 21, 167–172, https://doi.org/10.1016/j.coi.2009.02.005 (2009).
doi: 10.1016/j.coi.2009.02.005
pubmed: 19282163
pmcid: 2676210
Banerjee, A. et al. Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J. Immunol. 185, 4988–4992, https://doi.org/10.4049/jimmunol.1002042 (2010).
doi: 10.4049/jimmunol.1002042
pubmed: 20935204
Ichii, H. et al. Bcl6 acts as an amplifier for the generation and proliferative capacity of central memory CD8+ T cells. J. Immunol. 173, 883–891, https://doi.org/10.4049/jimmunol.173.2.883 (2004).
doi: 10.4049/jimmunol.173.2.883
pubmed: 15240675
Fateh, H. L. et al. The effect of Vit-D supplementation on the side effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response against SARS-CoV-2 in the individuals tested positive for COVID-19: a randomized control trial. Clin. Nutr. Res. 12, 269–282, https://doi.org/10.7762/cnr.2023.12.4.269 (2023).
doi: 10.7762/cnr.2023.12.4.269
pubmed: 37969936
pmcid: 10641329
Fatih, C. et al. Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: a randomized controlled trial. Vaccine. 41, 2860–2867 (2023). https://doi.org/10.1016/j.vaccine.2023.03.046 .
Piec, I. et al. Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine. Curr. Res. Transl. Med. 70, 103344, https://doi.org/10.1016/j.retram.2022.103344 (2022).
doi: 10.1016/j.retram.2022.103344
pubmed: 35390564
pmcid: 8923881
Jolliffe, D. A. et al. Influence of Vitamin D supplementation on SARS-CoV-2 vaccine efficacy and immunogenicity. MedRxiv (Cold Spring Harbor Laboratory). (2022), https://doi.org/10.1101/2022.07.15.22277678 .
Jolliffe, D. A. et al. Vitamin D supplementation does not influence SARS-CoV-2 vaccine efficacy or immunogenicity: sub-studies nested within the CORONAVIT randomised controlled trial. Nutrients 14, 3821, https://doi.org/10.3390/nu14183821 (2022).
doi: 10.3390/nu14183821
pubmed: 36145196
pmcid: 9506404
Kofahi, H. M. et al. Exploring the effects of vitamin D and vitamin a levels on the response to COVID-19 Vaccine. Vaccines 11, 1509, https://doi.org/10.3390/vaccines11091509 (2023).
doi: 10.3390/vaccines11091509
pubmed: 37766185
pmcid: 10535137
Meyers, E. et al. No significant association between 25-OH vitamin D status and SARS-CoV-2 antibody response after COVID-19 vaccination in nursing home residents and staff. Vaccines 11, 1343, https://doi.org/10.3390/vaccines11081343 (2023).
doi: 10.3390/vaccines11081343
pubmed: 37631911
pmcid: 10458709
Chillon, T. S. et al. Relationship between vitamin D status and antibody response to COVID-19 mRNA vaccination in healthy adults. Biomedicines 9, 1714, https://doi.org/10.3390/biomedicines9111714 (2021).
doi: 10.3390/biomedicines9111714
pubmed: 34829945
pmcid: 8615783
Björkhem-Bergman, L. et al. Vitamin D binding protein is not affected by high-dose vitamin D supplementation: a post hoc analysis of a randomised, placebo-controlled study. BMC Res. Notes 11, 619, https://doi.org/10.1186/s13104-018-3725-7 (2018).
doi: 10.1186/s13104-018-3725-7
pubmed: 30157946
pmcid: 6114541